197 related articles for article (PubMed ID: 20553613)
61. [Establishment of a human pancreatic adenocarcinoma cell line(JF305) with p53 expression].
Li X; Wang H; Jiang Y
Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):181-3. PubMed ID: 7956694
[TBL] [Abstract][Full Text] [Related]
62. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
63. Apoptotic activity and antitumor efficacy of PEGylated TNF-related apoptosis-inducing ligand (TRAIL) in a Mia Paca-2 cell-xenografted mouse model.
Byeon HJ; Choi SH; Choi JS; Kim TH; Lee ES; Lee KC; Youn YS
Biomed Pharmacother; 2014 Feb; 68(1):65-9. PubMed ID: 24268811
[TBL] [Abstract][Full Text] [Related]
64. Perforin-dependent direct cytotoxicity in natural killer cells induces considerable knockdown of spontaneous lung metastases and computer modelling-proven tumor cell dormancy in a HT29 human colon cancer xenograft mouse model.
Brodbeck T; Nehmann N; Bethge A; Wedemann G; Schumacher U
Mol Cancer; 2014 Nov; 13():244. PubMed ID: 25373310
[TBL] [Abstract][Full Text] [Related]
65. Five primary human pancreatic adenocarcinoma cell lines established by the outgrowth method.
Rückert F; Aust D; Böhme I; Werner K; Brandt A; Diamandis EP; Krautz C; Hering S; Saeger HD; Grützmann R; Pilarsky C
J Surg Res; 2012 Jan; 172(1):29-39. PubMed ID: 21683373
[TBL] [Abstract][Full Text] [Related]
66. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer.
Holloway SE; Beck AW; Girard L; Jaber MR; Barnett CC; Brekken RA; Fleming JB
J Am Coll Surg; 2005 Mar; 200(3):371-7. PubMed ID: 15737847
[TBL] [Abstract][Full Text] [Related]
67. Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer.
Heider TR; Lyman S; Schoonhoven R; Behrns KE
Ann Surg; 2007 Jul; 246(1):61-8. PubMed ID: 17592292
[TBL] [Abstract][Full Text] [Related]
68. Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma.
Nagaoka K; Bai X; Ogawa K; Dong X; Zhang S; Zhou Y; Carlson RI; Jiang ZG; Fuller S; Lebowitz MS; Ghanbari H; Wands JR
Cancer Lett; 2019 May; 449():87-98. PubMed ID: 30768955
[TBL] [Abstract][Full Text] [Related]
69. Molecular profiling of direct xenograft tumors established from human pancreatic adenocarcinoma after neoadjuvant therapy.
Kim MP; Truty MJ; Choi W; Kang Y; Chopin-Lally X; Gallick GE; Wang H; McConkey DJ; Hwang R; Logsdon C; Abbruzzesse J; Fleming JB
Ann Surg Oncol; 2012 Jul; 19 Suppl 3(0 3):S395-403. PubMed ID: 21701930
[TBL] [Abstract][Full Text] [Related]
70. Overexpression of human Argonaute2 inhibits cell and tumor growth.
Zhang X; Graves P; Zeng Y
Biochim Biophys Acta; 2013 Mar; 1830(3):2553-61. PubMed ID: 23201202
[TBL] [Abstract][Full Text] [Related]
71. A deimmunized bispecific ligand-directed toxin that shows an impressive anti-pancreatic cancer effect in a systemic nude mouse orthotopic model.
Oh S; Todhunter DA; Panoskaltsis-Mortari A; Buchsbaum DJ; Toma S; Vallera DA
Pancreas; 2012 Jul; 41(5):789-96. PubMed ID: 22258068
[TBL] [Abstract][Full Text] [Related]
72. Differential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinoma.
Chaika NV; Yu F; Purohit V; Mehla K; Lazenby AJ; DiMaio D; Anderson JM; Yeh JJ; Johnson KR; Hollingsworth MA; Singh PK
PLoS One; 2012; 7(3):e32996. PubMed ID: 22412968
[TBL] [Abstract][Full Text] [Related]
73. Establishment and characterization of a new cell line, A99, from a primary small cell carcinoma of the pancreas.
Yachida S; Zhong Y; Patrascu R; Davis MB; Morsberger LA; Griffin CA; Hruban RH; Laheru D; Iacobuzio-Donahue CA
Pancreas; 2011 Aug; 40(6):905-10. PubMed ID: 21768923
[TBL] [Abstract][Full Text] [Related]
74. Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines.
Wennerström AB; Lothe IM; Sandhu V; Kure EH; Myklebost O; Munthe E
PLoS One; 2014; 9(8):e103873. PubMed ID: 25148029
[TBL] [Abstract][Full Text] [Related]
75. Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation.
Souchek JJ; Baine MJ; Lin C; Rachagani S; Gupta S; Kaur S; Lester K; Zheng D; Chen S; Smith L; Lazenby A; Johansson SL; Jain M; Batra SK
Br J Cancer; 2014 Sep; 111(6):1139-49. PubMed ID: 25025965
[TBL] [Abstract][Full Text] [Related]
76. Anticancer Activity of Sunitinib Analogues in Human Pancreatic Cancer Cell Cultures under Normoxia and Hypoxia.
Skaraitė I; Maccioni E; Petrikaitė V
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982496
[TBL] [Abstract][Full Text] [Related]
77. [Establishment and characterization of a human lung adenocarcinoma cell line, Ch-Huang-1].
Li B; Zhong K; Jin L; Yuan Y; Gong D; Liu X; Huang S
Zhongguo Fei Ai Za Zhi; 2012 May; 15(5):267-70. PubMed ID: 22613331
[TBL] [Abstract][Full Text] [Related]
78. Pharmacogenomic modeling of circulating tumor and invasive cells for prediction of chemotherapy response and resistance in pancreatic cancer.
Yu KH; Ricigliano M; Hidalgo M; Abou-Alfa GK; Lowery MA; Saltz LB; Crotty JF; Gary K; Cooper B; Lapidus R; Sadowska M; O'Reilly EM
Clin Cancer Res; 2014 Oct; 20(20):5281-9. PubMed ID: 25107917
[TBL] [Abstract][Full Text] [Related]
79. Macrophage scavenger receptor a promotes tumor progression in murine models of ovarian and pancreatic cancer.
Neyen C; Plüddemann A; Mukhopadhyay S; Maniati E; Bossard M; Gordon S; Hagemann T
J Immunol; 2013 Apr; 190(7):3798-805. PubMed ID: 23447685
[TBL] [Abstract][Full Text] [Related]
80. Altered Mitochondria Functionality Defines a Metastatic Cell State in Lung Cancer and Creates an Exploitable Vulnerability.
Chuang CH; Dorsch M; Dujardin P; Silas S; Ueffing K; Hölken JM; Yang D; Winslow MM; Grüner BM
Cancer Res; 2021 Feb; 81(3):567-579. PubMed ID: 33239425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]